Potential Role for CAR T-Cell Therapy in MM at Early Relapse
Krina Patel, MD, reviews data from the CARTITUDE-4 and KarMMa-3 studies and shares perspectives on a potential role for CAR T-cell therapy at early relapse.
Source: onclive.com
Cartitude 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cartitude 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cartitude 2 Today - Breaking & Trending Today
CIBMTR Registry and CARTITUDE-2: Trial of Cilta-Cel in Patients with MM
Dr. Abonour and Dr. Raje provide an overview of the results that were presented at ASH 2023 of the CIBMTR registry and CARTITUDE-2 trial which was the study of ciltacabtagene autoleucel (cilta-cel) in patients with MM and 1-3 prior lines of therapy (Cohort A) and with early relapse after first line treatment (cohort B).
Source: onclive.com